The Dividend Yield as of November 2024 (TTM) for ImmunityBio, Inc. (IBRX) is 0%

According to ImmunityBio, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

ImmunityBio, Inc. (IBRX) Historical Dividend Yield (quarterly & annually)

How has IBRX Dividend Yield performed in the past?

The mean historical Dividend Yield of ImmunityBio, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), IBRX's Dividend Yield was at its highest in in the December 2017 quarter at 0.08%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

ImmunityBio, Inc. (IBRX) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of ImmunityBio, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmunityBio, Inc. (IBRX) Average Dividend Yield

How has IBRX Dividend Yield performed in the past?

The current Dividend Yield of ImmunityBio, Inc. (IBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ImmunityBio, Inc. (IBRX) Dividend Yield vs. Peers

How is IBRX’s Dividend Yield compared to its peers?

ImmunityBio, Inc.’s Dividend Yield is less than BioLineRx Ltd. (0%), less than Ardelyx, Inc. (0%), less than Lexicon Pharmaceuticals, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%), less than Protalix BioTherapeutics, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than aTyr Pharma, Inc. (0%), less than Elevation Oncology, Inc. (0%), less than CureVac N.V. (0%), less than Reata Pharmaceuticals, Inc. (0%), less than Krystal Biotech, Inc. (0%), less than Vir Biotechnology, Inc. (0%), less than Propanc Biopharma, Inc. (0%), less than Viking Therapeutics, Inc. (0%), less than TG Therapeutics, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Madrigal Pharmaceuticals, Inc. (0%), less than null (0%),

Build a custom stock screener for ImmunityBio, Inc. (IBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunityBio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunityBio, Inc. (IBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunityBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.